These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25854343)

  • 1. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
    Du Y; Chen X; Lin XQ; Wu W; Huang ZM
    Asian Pac J Cancer Prev; 2015; 16(7):2665-9. PubMed ID: 25854343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4.
    Chen X; Du Y; Hu Q; Huang Z
    Pathol Res Pract; 2017 Mar; 213(3):245-249. PubMed ID: 28214198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
    Zhou S; Chen L; Qin J; Li R; Tao H; Zhen Z; Chen H; Chen G; Yang Y; Liu B; She Z; Zhong C; Liang C
    PLoS One; 2013; 8(9):e73952. PubMed ID: 24023916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.
    Kulhankova K; Rouse T; Nasr ME; Field EH
    PLoS One; 2012; 7(9):e43609. PubMed ID: 22984435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
    Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
    Brinster C; Shevach EM
    J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive effects of CD4
    Zhou P; Xu J; Dai M; Shi Y; Wu G; Fang Y; Yan X
    J Viral Hepat; 2018 Jun; 25(6):733-741. PubMed ID: 29345851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
    Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
    J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
    Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
    Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
    Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
    Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
    Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
    Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.
    Radhakrishnan S; Cabrera R; Schenk EL; Nava-Parada P; Bell MP; Van Keulen VP; Marler RJ; Felts SJ; Pease LR
    J Immunol; 2008 Sep; 181(5):3137-47. PubMed ID: 18713984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.
    Hotta-Iwamura C; Benck C; Coley WD; Liu Y; Zhao Y; Quiel JA; Tarbell KV
    J Autoimmun; 2018 Jun; 90():39-48. PubMed ID: 29439835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
    Ovcinnikovs V; Ross EM; Petersone L; Edner NM; Heuts F; Ntavli E; Kogimtzis A; Kennedy A; Wang CJ; Bennett CL; Sansom DM; Walker LSK
    Sci Immunol; 2019 May; 4(35):. PubMed ID: 31152091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.